Gosselies, Belgium – Évry, France July 9th, 2020
This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.
Webinar
Webinar : Comprehensive Genomic Profiling: What’s the Business Case? Hear the experience of an existing OncoDEEP® Kit customer
Is Comprehensive Genomic Profiling right for your lab? Wednesday, December 11, 20244:00 PM CET By Dr. Marcel Trautmann (Head of Molecular Diagnostics – Division of Translational Pathology – Universitätsklinikum Münster) In today’s evolving landscape, labs...